Atlas Trials

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT03389295 · COMPLETED

Trial details

NCT number
NCT03389295
Sponsor
Xiayun He, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2010-01-01
Primary completion
2019-04-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.